Home
>
National Drug Code (NDC)
>
VAQTA
VAQTA - 0006-4831-41 - (hepatitis A vaccine, inactivated)
Drug Information of VAQTA
| Product NDC: | 0006-4831 |
| Proprietary Name: | VAQTA |
| Non Proprietary Name: | hepatitis A vaccine, inactivated |
| Active Ingredient(s): | 25 [iU]/.5mL & nbsp; hepatitis A vaccine, inactivated |
| Administration Route(s): | INTRAMUSCULAR |
| Dosage Form(s): | INJECTION, SUSPENSION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of VAQTA
| Product NDC: | 0006-4831 |
| Labeler Name: | Merck Sharp & Dohme Corp. |
| Product Type: | VACCINE |
| FDA Application Number: | BLA103606 |
| Marketing Category: | BLA |
| Start Marketing Date: | 19960329 |
Package Information of VAQTA
| Package NDC: | 0006-4831-41 |
| Package Description: | 10 VIAL, SINGLE-DOSE in 1 CARTON (0006-4831-41) > .5 mL in 1 VIAL, SINGLE-DOSE (0006-4831-01) |
NDC Information of VAQTA
| NDC Code | 0006-4831-41 |
| Proprietary Name | VAQTA |
| Package Description | 10 VIAL, SINGLE-DOSE in 1 CARTON (0006-4831-41) > .5 mL in 1 VIAL, SINGLE-DOSE (0006-4831-01) |
| Product NDC | 0006-4831 |
| Product Type Name | VACCINE |
| Non Proprietary Name | hepatitis A vaccine, inactivated |
| Dosage Form Name | INJECTION, SUSPENSION |
| Route Name | INTRAMUSCULAR |
| Start Marketing Date | 19960329 |
| Marketing Category Name | BLA |
| Labeler Name | Merck Sharp & Dohme Corp. |
| Substance Name | HEPATITIS A VIRUS STRAIN CR 326F ANTIGEN (FORMALDEHYDE INACTIVATED) |
| Strength Number | 25 |
| Strength Unit | [iU]/.5mL |
| Pharmaceutical Classes | Inactivated Hepatitis A Virus Vaccine [EPC],Actively Acquired Immunity [PE],Hepatitis A Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient] |
